Stocks
Intra-Cellular Therapies (ITCI) ROA US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -31.6% | -58.0% | -34.0% | -19.2% | -5.46% | -5.46% | ||
| Changes by years, y/y, % | +27pp | -26pp | +24pp | +15pp | +14pp | -37.8% | |||
Intra-Cellular Therapies. ROA, %
Intra-Cellular Therapies. ROA, changes, pp
Intra-Cellular Therapies (ITCI) ROA US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | LTM ? | |||
| ROA, % | ? | -19.2% | -14.8% | -6.38% | -6.52% | -5.46% | -5.46% | |
| Changes by years, y/y, % | +14pp | +15pp | +19pp | +14pp | +14pp | |||
| Changes by quarters, q/q, % | +1pp | +4pp | +8pp | 0pp | +1pp | |||
